MCHALE DUNCAN (Chief Medical Officer) sold 15.4% of their position (3.10K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $1.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/8/2023ACC: 0001694665-23-000178
Officer· Chief Medical Officer
Since Jan 2020
-3.10K
Net shares
Net seller
$1.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.50K acquired · 9.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
—
Trade value
—
% of position
47.8%
11/7/2023
13.59K→20.09K
Common Stock
Direct
Shares
−3.10K
Price / share
$0.33
Trade value
$1.02K
% of position
15.4%
11/8/2023
20.09K→16.98K
Total
Net shares
+3.40K
Net value
-$1.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/7/2023 | M · Option Exercise | +6.50K | — | — | 47.8% | 13.59K | 20.09K |
| Common Stock Direct | 11/8/2023 | S · Sale | −3.10K | $0.33 | $1.02K | 15.4% | 20.09K | 16.98K |
| Total | +3.40K | -$1.02K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.50K shares
Shares
−6.50K
Strike price
Held after
6.50K
Exercisable
—
11/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.50K shares | 11/7/2023 | M · Option Exercise | −6.50K | — | 6.50K |